• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Tetraphase Pharmaceuticals Inc

+ Add to Watchlist

7TP:GR

8.033 EUR 0.063 0.79%

As of 02:17:44 ET on 07/22/2014.

Snapshot for Tetraphase Pharmaceuticals Inc (7TP)

Open: 8.033 Day's Range: 8.033 - 8.033 Volume: 0
Previous Close: 7.970 52wk Range: 5.547 - 12.690 1-Yr Rtn: +36.71%

Stock Chart for 7TP

No chart data available.
  • 7TP:GR 8.033
  • 1D
  • 1M
  • 1Y
7.970
Interactive 7TP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 7TP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -2.1350
Est. PEG Ratio -
Market Cap (M EUR) 207.52
Shares Outstanding (M) 25.83
30 Day Average Volume 258
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 7TP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 7TP

Tetraphase Pharmaceuticals, Inc. develops and commercializes tetracycline based drugs to treat drug-resistant infectious diseases, inflammation, and cancer. The Company offers intravenous antibiotic products with oral stepdown potential effective against difficult-to-treat and multidrug-resistant pathogens. Tetraphase conducts business in the United States.

Guy MacdonaldPresident/CEOJ Craig ThompsonChief Operating Officer
Patrick T HornChief Medical OfficerDavid C LubnerSenior VP/CFO
More Company Profile & Key Executives for 7TP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil